Serum antibody response in critically ill patients with COVID-19

Intensive Care Med. 2020 Oct;46(10):1921-1923. doi: 10.1007/s00134-020-06171-7. Epub 2020 Jul 8.

Alban Longchamp^#^{1

2

3}, Justine Longchamp^#^{1

3}, Antony Croxatto⁴, Gilbert Greub⁴, Bienvenido Sanchez^#⁵, Julie Delaloye^#⁶; Study Group

Study Group:
Livia Whiting, Séverin Jeanneret, Alix T Coste, Alexis Dumoulin, Stéphane Emonet, Raymond Friolet

¹ Department of Intensive Care Medicine, Centre Hospitalier du Valais Romand de l'Hôpital du Valais, (Site de Sion) Avenue du Grand-Champsec 80, 1951, Sion, Switzerland.
² Department of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland.
³ Department of Vascular Surgery, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland.
⁴ Department of Laboratory Medicine and Pathology, Institute of Microbiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
⁵ Department of Intensive Care Medicine, Centre Hospitalier du Valais Romand de l'Hôpital du Valais, (Site de Sion) Avenue du Grand-Champsec 80, 1951, Sion, Switzerland. bienvenido.sanchez@hopitalvs.ch.
⁶ Department of Intensive Care Medicine, Centre Hospitalier du Valais Romand de l'Hôpital du Valais, (Site de Sion) Avenue du Grand-Champsec 80, 1951, Sion, Switzerland. Julie.Delaloye@hopitalvs.ch.

^# Contributed equally.

No abstract available

Publication types